Subscribe to Search results

In his written statement, Professor John Gillon noted that there was no doubt that screening with one or both of the the ALT or anti-HBc screening tests would have prevented some cases of NANBH, and in spite of the lack of data on the incidence of PTNANBH this would have been a desirable outcome.

Published on:

In a written submission to the Inquiry, SNBTS stated that they have on balance reached the conclusion that surrogate testing for NANBH should have been introduced.

Published on:

Alter et al wrote in the New England Journal of Medicine that 'surrogate assays for anti-HBc and alanine aminotransferase would have detected approximately half the anti-HCV-positive donors involved in the transmission of hepatitis they had identified.

Published on:

A study from Canada, published in the Lancet, found that 70 percent of hepatitis C infections would have been avoided by the use of the two surrogate markers, ALT and anti HBc.

Published on:

Journal article titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' described chronic NANBH as symptomatically mild and unaccompanied by physical signs or laboratory evidence of autoimmune disease or severe chronic liver disease..

Published on:

A report on NANB Hepatitis was prepared for the ACVSB. It described the issue of surrogate testing for NANBH as being "of some urgency" and suggested that it be a major item for the next meeting.

Published on:

Alter et al published a paper titled 'The Chronic Sequelae of Non-A Non-B Hepatitis B' in the Annals of Internal Medicine journal.

Published on:

The maximum pool size at BPL increased to 5,000 donations.

Published on:

Capacity to accommodate larger pool sizes increased at PFC.

Published on:

Maximum pool sizes at BPL increased to 7,500 donations.

Published on:

Maximum pool sizes at BPL increased to 10,000 donations.

Published on:

A blood donor diagnosed with AIDS at Bournemouth Hospital.

Published on:

The CMO publicly confirmed that the donations of a blood donor, who had been diagnosed with AIDs, had been traced.

Published on:

The regional transfusion directors agreed that the blood services would make the initial approach to a donor where a positive donation was found.

Published on:

At the EAGA meeting, Dr Contreras said AIDS patients should be asked if they had donated blood in the last five years.

Published on:

Blood in the UK started to be screened for HIV.

Published on:

A five-year lookback programme was introduced.

Published on:

At the EAGA meeting, Dr Tedder asked members to consider asking seropositive patients if they had donated blood since 1978.

Published on:

At the EAGA meeting, Dr Contreras asked again that clinicians routinely ask patients with HTLV-3 antibodies or AIDS if they had donated blood.

Published on:

CMO's Dear Doctor letter asked clinicians to ask whether HTLV-3 patients ever donated blood.

Published on: